Role of CX3CL1 in synaptic activity and neuroprotection

Chemokine Receptors and NeuroAIDS: Beyond Co-Receptor Function and Links to Other Neuropathologies

Volumn , Issue , 2010, Pages 301-316

  Ragozzino, Davide ^a   Lauro, Clotilde ^a   Limatola, Cristina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884814864     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0793-6_13     Document Type: Chapter

References (90)

1. Bazan JF, Bacon KB, Hardiman G et al (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644.
2. Bertollini C, Ragozzino D, Gross C et al (2006) Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacol 51:816-821.
3. Boddeke EW, Meigel I, Frentzel S et al (1999) Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia. Eur J Pharmacol 374:309-313.
4. Boheme SA, Lio FM, Maciejewski-Lenoir D et al (2000) The chemokine fractalkine inhibits Fasmediated cell death of brain microglia. J Immunol 165:397-403.
5. Cambien B, Pomeranz M, Schmid-Antonmarchi H et al (2001) Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 97:2031-2037.
6. Cardona AE, Pioro EP, Sasse ME et al (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9:917-924.
7. Chapman GA, Moores K, Harrison D et al (2000) Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci 20:RC87.
8. Chen S, Luo D, Streit WJ et al (2002) TGF-b1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J Neuroimmunol 133:46-55.
9. Chen X, Geller EB, Rogers TJ et al (2007) The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats. Brain Res 11:1153-1157.
10. Clark AK, Yip PK, Grist J et al (2007) Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci USA 104:10655-10660.
11. Combadiere C, Ahuia SK, Murphy PM (1995) Cloning, chromosomal localization, and RNA expression of a human beta chemokine receptor-like gene DNA. Cell Biol 14:673-680.
12. Combadiere C, Gao J, Tiffany HL et al (1998a) Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine. Biochem Biophys Res Commun 253:728-732.
13. Combadiere C, Salzwedel K, Smith ED et al (1998b) Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J Biol Chem 273:23799-23804.
14. Cotter R, Williams C, Ryan L et al (2002) Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia. J Neurovirol 8:585-598.
15. Cunha-Reis D, Ribeiro JA, Sebastião AM (2008) A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K + -evoked [3H]-GABA release from rat hippocampal nerve terminals. Neurosci Lett 430:207-212.
16. Davalos D, Grutzendler J, Yang G et al (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752-758.
17. Davis CN, Harrison JK (2006) Proline 326 in the C terminus of murine CX3CR1 prevents G-protein and phosphatidylinositol 3-kinase-dependent stimulation of Akt and extracellular signal-regulated kinase in Chinese hamster ovary cells. J Pharmacol Exp Ther 316:356-363.
18. de Haas AH, van Weering HRJ, de Jong EK et al (2007) Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol 36:137-151.
19. Deiva K, Geeraerts T, Salim H et al (2004) Fractalkine reduces N-methyl-d-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation. Eur J Neurosci 20:3222-3232.
20. Dorf ME, Berman MA, Tanabe S et al (2000) Astrocytes express functional chemokine receptors. J Neuroimmunol 111:109-121.
21. Erichsen D, Lopez AL, Peng H et al (2003) Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J Neuroimmunol 138:144-155.
22. Faure S, Meyer L, Costagliola D et al (2000) Rapid progression to AIDS in HIV1 individuals with a structural variant of the chemokine receptor CX3CR1. Science 287:2274-2277.
23. Fong AM, Erickson HP, Zachariah JP et al (2000) Ultrastructure and function of the fractalkine mucin domain in CX3C chemokine domain presentation. J Biol Chem 275:3781-3786.
24. Garin A, Tarantino N, Faure S et al (2003) Two novel fully functional isoforms of CX3CR1 are potent HIV coreceptors. J Immunol 171:5305-5312.
25. Garton KJ, Gough PJ, Blobel CP et al (2001) Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276:37993-38001.
26. Gillard SE, Lu M, Mastracci RM (2002) Expression of functional chemokine receptors by rat cerebellar neurons. J Neuroimmunol 124:16-28.
27. Guyon A, Nahon JL (2007) Multiple actions of the chemokine stromal cell-derived factor-1a on neuronal activity. J Mol Endocrinol 38:365-376.
28. Harrison JK, Barber CM, Lynch KR (1994) cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors. Neurosci Lett 169:85-89.
29. Harrison JK, Jiang Y, Chen S et al (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 95:10896-10901.
30. Hatori K, Nagai A, Heisel R et al (2002) Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 69:418-426.
31. Holmes FE, Arnott N, Vanderplank P et al (2008) Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. J Neurochem 106:640-649.
32. Huang DR, Shi FD, Jung S et al (2006) The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 20:896-905.
33. Hughes PM, Botham MS, Frentzel S et al (2002) Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37:314-327.
34. Hulshof S, van Haasters ES, Kuipers HF et al (2003) CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J Neuropathol Exp Neurol 62:899-907.
35. Hundhausen C, Misztela D, Berkhout TA et al (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186-1195.
36. Imai T, Hieshima K, Haskell C et al (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521-530.
37. Ji JF, He BP, Dheen ST et al (2004) Interaction of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22:415-427.
38. Ji JF, Dheen ST, Kumar SD et al (2005) Expressions of cytokines and chemokines in the dorsal motor nucleus of the vagus nerve after right vagotomy. Mol Brain Res 142:47-57.
39. Jiang Y, Salafranca MN, Adhikari S et al (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J Neuroimmunol 86:1-12.
40. Johnston IN, Milligan ED, Wieseler-Frank J et al (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 24:7353-7365.
41. Jung S, Aliberti J, Graemmel P et al (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20:4106-4114.
42. Kansra V, Groves C, Gutierrez-Ramos JC et al (2001) Phosphatidylinositol 3-kinase-dependent extracellular calcium influx is essential for CX3CR1-mediated activation of the mitogenactivated protein kinase cascade. J Biol Chem 276:31831-31838.
43. Kastenbauer S, Koedel U, Wick M et al (2003) CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J Neuroimmunol 137:210-217.
44. Kim TS, Lim HK, Lee JY et al (2008) Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 436:196-200.
45. Krathwohl MD, Kaiser JL (2004) Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22:109-118.
46. Lauro C, Catalano M, Trettel F et al (2006) The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependent on the beta1 integrin subunit. J Immunol 177:7599-7606.
47. Lauro C, Di Angelantonio S, Cipriani R et al (2008) Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J Immunol 180:7590-7596.
48. Lee RH, Hsu SC, Munoz J et al (2006) A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 107:2153-2161.
49. Lee SR, Guo SZ, Scannevin RH et al (2007) Induction of matrix metalloproteases and chemokines in rat cortical astrocytes exposed to plasminogen activators. Neurosci Lett 417:1-5.
50. Limatola C, Lauro C, Catalano M et al (2005) Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J Neuroimmunol 166:19-28.
51. Lindia JA, McGowan E, Jochnowitz N et al (2005) Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain 6:434-438.
52. Luongo L, Sajic M, Grist J et al (2008) Spinal changes associated with mechanical hypersensitivity in a model of Guillain-Barré syndrome. Neurosci Lett 437:98-102.
53. Maciejewski-Lenoir D, Chen S, Feng L et al (1999) Characterization of fractalkine in rat brain cells: Migratory and activation signals for CX3CR-1-expressing microglia. J Immunol 163:1628-1635.
54. Matloubian M, David A, Engel S et al (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1:298-304.
55. McDermott DH, Colla JS, Kleeberger CA et al (2000) Genetic polymorphism in CX3CR1 and risk of HIV disease. Science 290:2274-2277.
56. Meucci O, Fatatis A, Simen AA et al (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 95:14500-14505.
57. Meucci O, Fatatis A, Simen AA et al (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 97:8075-8080.
58. Mizuno T, Kawanokuchi J, Numata K et al (2003) Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 979:65-70.
59. Milligan ED, Zapata V, Chacur M et al (2004) Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 20:2294-2302.
60. Milligan E, Zapata V, Schoeniger D et al (2005) An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur J Neurosci 22:2775-2782.
61. Moatti D, Faure S, Fumeron F et al (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925-1928.
62. Mody M, Cao Y, Cui Z et al (2001) Genome-wide gene expression profiles of the developing mouse hippocampus. Proc Natl Acad Sci USA 98:8862-8867.
63. Murphy PM, Baggiolini M, Charo IF et al (2000) International union of pharmacology XXII nomenclature for chemokine receptors. Pharmacol Review 52:145-176.
64. Nishiyori A, Minami M, Ohtani Y et al (1998) Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429:167-172.
65. Oh SB, Tran PB, Gillard SE et al (2001) Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21:5027-5035.
66. Oh SB, Endoh T, Simen AA et al (2002) Regulation of calcium currents by chemokines and their receptors. J Neuroimmunol 123:66-75.
67. Pan Y, Lloyd C, Zhou H et al (1997) Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611-617.
68. Pereira CF, Middel J, Jansen G et al (2001) Enhanced expression of fractalkine in HIV-1 associated dementia. J Neuroimmunol 115:168-175.
69. Ragozzino D, Di Angelantonio S, Trettel F et al (2006) Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J Neurosci 26:10488-10498.
70. Raport CJ, Schweickart VL, Eddy RL et al (1995) The orphan G-protein-coupled receptorencoding gene V28 is closely related to genes for chemokine receptors and is expressed in lymphoid and neural tissues. Gene 163:295-299.
71. Reeves JD, McKnight A, Potempa S et al (1997) CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 231:130-134.
72. Ribeiro JA (2005) What can adenosine neuromodulation do for neuroprotection? Curr Drug Targets CNS Neurol Disord 4:325-329.
73. Rucker J, Edinger AL, Sharron M et al (1997) Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 71:8999-9007.
74. Schwaeble WJ, Stover CM, Schall TJ et al (1988) Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett 439:203-207.
75. Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361-1368.
76. Soriano SG, Amaravadi LS, Wang YF et al (2002) Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 125:59-65.
77. Sun S, Cao H, Han M et al (2007) New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis. Pain 129:64-75.
78. Sunnemark D, Eltayeb S, Nilsson M et al (2005) CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. Neuroinflammation 2:17.
79. Tarozzo G, Bortolazzi C, Crochemore S et al (2003) Fractalkine protein localization and gene expression in mouse brain. J Neurosci Res 73:81-88.
80. Tarozzo G, Campanella M, Ghiani M et al (2002) Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur J Neurosci 15:1663-1668.
81. Tong N, Perry SW W, Zhang Q et al (2000) Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol 164:1333-1339.
82. Tsou CL, Haskell CA, Charo IF (2001) Tumor necrosis factor-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 276:44622-44626.
83. Verge GM, Milligan ED, Maier SF et al (2004) Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 20:1150-1160.
84. Vidal F, Viladés C, Domingo P et al (2005) Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele. J Acquir Immune Defic Syndr 40:527-531.
85. Vitale S, Schmid-Alliana A, Breuil V et al (2004) Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte migration via inhibition of stress-activated protein kinase 2/p38 and matrix metalloproteinase activities. J Immunol 172:585-592.
86. Zhuang ZY, Kawasaki Y, Tan PH et al (2007) Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21:642-651.
87. Zujovic V, Benavides J, Vigé X et al (2000) Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29:305-315.
88. Zujovic V, Schussler N, Jourdain D et al (2001) In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS. J Neuroimmunol 115:135-143.
89. Yoshida H, Imaizumia T, Fujimotoa K et al (2001) Synergistic stimulation, by tumor necrosis factora and interferon-g, of fractalkine expression in human astrocytes. Neurosci Lett 303:132-136.
90. Xu Q, Wang S, Ishida X et al (2007) Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro. Clin Exp Pharmacol Physiol 34:624-631.